Pharmaceutical Business Intelligence Reports
Showing 409–420 of 709 results
-
Drug Patent Reports
OSPHENA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
OTOVEL Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
OXBRYTA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
OXLUMO Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
OZEMPIC Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PARAFFIN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
PARSABIV Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PEANUT OIL Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PEG-100 STEARATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PEG-40 SORBITAN DIISOSTEARATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PEG-75 LANOLIN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PEGOXOL 7 STEARATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart
